Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes

Cancer Letters(2020)10.1016/j.canlet.2020.12.014Source: DataRank Database

Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes is a research paper published in Cancer Letters (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.46)OA: greenTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

P. Campbell ORCID,Jonathan Wooten,Joyce Aja ORCID,Melissa B. Davis ORCID,Andrea Loaiza‐Perez

Live enrichment

PubMed:33309858 PMC:PMC7872014 OpenAlex:https://openalex.org/W3113213652

NIGMS NIH HHS

Grant: R25 GM060507

National Institutes of Health

Grant: 5R25GM060507-02

LLU-NIH MINORITY STUDENT DEVELOPMENT PROGRAM

Consejo Nacional de Investigaciones Científicas y Técnicas

National Institutes of Health

FWCI

0.46

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7872014

publisherhttps://api.elsevier.com/content/article/PII:S0304383520306649?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383520306649?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.canlet.2020.12.014

Fields of Study

Cancer Cells and MetastasisCancer-related Molecular PathwaysCancer Genomics and Diagnostics03 medical and health sciences0302 clinical medicineAntineoplastic Agents, HormonalBreast NeoplasmsDrug Resistance, NeoplasmFemaleFulvestrantHumansNeoplasm Recurrence, LocalNeoplastic Stem CellsProto-Oncogene Proteins c-aktErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenSignal Transduction

MeSH Terms

FulvestrantBreast NeoplasmsFemaleHumansNeoplasm Recurrence, LocalReceptors, EstrogenNeoplastic Stem CellsSignal TransductionErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Antineoplastic Agents, HormonalDrug Resistance, NeoplasmProto-Oncogene Proteins c-akt

Keywords

Breast cancerCancerEndocrine systemCancer researchProtein kinase BInternal medicineStem cellBiologyHormoneOncologyEndocrinologyMedicineSignal transductionCell biologyStem CellsEndocrine TherapyDisparitiesEndocrine ResistanceAntineoplastic Agents, HormonalBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenDrug Resistance, Neoplasmhttps://purl.org/becyt/ford/3.1Neoplastic Stem CellsHumansFemalehttps://purl.org/becyt/ford/3Neoplasm Recurrence, LocalFulvestrantProto-Oncogene Proteins c-akt

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being